Archive · 1 Jan 2026
Vijay Kedia Invests in Struggling Mangalam Drugs
Vijay Kedia, a well-known investor in India, has bought shares of a company called Mangalam Drugs and Organics Ltd.
This company has been doing poorly, with its stock price dropping by 80% over the past year.
Kedia believes that the company has good potential and is worth investing in, even though it is currently losing money.
He thinks that the company's assets, such as its manufacturing plants and products, are valuable and that the stock is undervalued.
However, investing in this company is risky because it is not making a profit and its stock price is very volatile.
Kedia's investment has caused the stock price to rise slightly, but it is still unclear if the company will be able to turn things around.
Vijay Kedia invested Rs 33 lakhs in Mangalam Drugs and Organics Ltd. at Rs 24 per share.
The company has seen an 80% drop in stock price over the past year, with significant financial struggles.
Kedia's 'SMILE' philosophy focuses on investing in small, struggling companies with large potential.
Mangalam Drugs has been a key player in the chemical industry since 1977, manufacturing APIs for various critical treatments.
The company faces several risks, including pledged promoter shares, high volatility, and uncertain turnaround prospects.
- Who
- Vijay Kedia, a prominent investor known for his 'SMILE' philosophy.
- What
- Investment in Mangalam Drugs and Organics Ltd.
- When
- December 29, 2025.
- Where
- The investment was made in the Indian stock market.
- Why
- Kedia sees potential in the company's turnaround despite its current financial struggles.
- Investor
- Vijay Kedia
- Company
- Mangalam Drugs and Organics Ltd.
- Stock Price
- Rs 24 per share
- Investment Amount
- Rs 33 lakhs
- Market Cap
- Rs 44 Cr
- Promoter Pledged Shares
- 34.6%
- Beta
- 1.22
- Debt-to-Equity Ratio
- 0.65